To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
Clinical trial NCT02723591 · COMPLETED
Trial details
- NCT number
- NCT02723591
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-09
- Primary completion
- 2019-06-14
- Enrollment
- 599
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.